Goose launches new solution for pharma industry

Top Stories

»	Sensex, Nifty open 1 pc lower amid West Asia tensions, weak global cues
»	India clocks robust 7.7 pc GDP growth in 2025-26, Q4 growth at 7.8 pc
»	RBI keeps repo rate unchanged at 5.25 pc, maintains ‘Neutral’ stance
»	Crude oil prices fall over 1 pc as ceasefire hopes ease West Asia concerns
»	Forced labour import curbs: US proposes up to 12.5 pc tariff on 60 countries, including India

SME Times News Bureau | 28 May, 2013
Pharmaceutical business re-engineering solutions pioneer Goose Monday announced the launch of 'Goose quality manager' to help track and manage the deviations effectively.

The solution is designed to offer real-time corrective measures to tackle deviation across product manufacturing lifecycles that can disrupt good manufacturing norms and result in millions of dollars in revenue loss for the industry.

'Goose quality manager' provides real time visibility into various quality events and is loaded with critical modules to deal with non-conformances, internal and external audits, change management, Corrective Action and Preventive Action (CAPA), complaints and other modules for business functions, said a statement by the Hyderabad-based company.

Available both in basic as well as advanced version, what sets 'Goose Quality Manager' apart from currently available solution is its time to deploy and cost of deployment.

The significantly lower investment solution can be deployed in less than 3-4 months in organization of any size.

"Each manufacturing cycle is comprised of hundreds of steps and it is extremely difficult to manage deviations at each step when tens and hundreds of batches of different pharmaceutical formulations are running in parallel on any given day. Deviations that are not tracked and corrected can lead to adverse events like customer complaints, alerts and recalls which cause loss in revenue as well as brand value," said Deb Pattnaik, founder and CEO of Goose.